Clinical Trial Update: Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A pilot study investigating anlotinib combined with the STUPP regimen in newly diagnosed glioblastoma has completed Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED